Benjamin L Palleiko

CHIEF EXECUTIVE OFFICER

Benjamin L Palleiko (CHIEF EXECUTIVE OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in KALV. The largest single filing was $293K of KALV (10,926 sh × $26.78, as filed), executed May 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.0M

shares × price, as filed

Last traded

May 22

Filed May 26

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 6 filings

Sector per market data · by filing · past 12 months

Most traded names

KALV KALV KALV · 0 buys · 12 sells 12 filings

Recent filings

KALVSALE KalVista Pharmaceuticals, Inc. View filing → $517K
32,979 sh × $15.69
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $104K
7,169 sh × $14.50
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $119K
9,999 sh × $11.88
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $133K
14,400 sh × $9.26
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET